• Life sciences, R&D

    pharmaceutical law / health care / proceedings before regulators / pharmacy and medical activities / medicinal products / medical devices / dietary supplements / contract manufacturing / sales and marketing of regulated products, including dietary supplements / product liability / pharmacovigilance / e-commerce in the pharmaceutical market / franchising / consolidation of the medical and pharmaceutical industry / commercialization of scientific research / spin offs & spin outs / science and business / scientific and research consortia / protection of commercialized intellectual property / patents / commercialization of research /

Expertise

  • Advising pharmaceutical, medical and food industry entities on day-to-day operations

  • Administrative proceedings before regulators

  • Court proceedings

  • Handling mergers and acquisitions of entities in the pharmaceutical and medical device industry

  • Providing advice on the manufacturing, import, marketing and distribution of medicinal products, medical devices and dietary supplements

  • Conducting audits of processes in terms of compliance with industry regulations and implementation of appropriate procedures

  • Providing advertising and marketing services of medicinal products, medical devices and dietary supplements

  • Legislative and industry monitoring

  • Training in regulatory aspects of business operations

  • Effective commercialisation of intangible assets

  • evelopment of strategies for the protection of intellectual property and its commercialization in R&D projects

  • Negotiation of agreements (consortia, licenses, joint rights, etc.) necessary for the implementation of R&D projects

Experience

Purchase of a company running pharmacies

Our lawyers represented the purchaser in concluding a contract for the purchase of 100% of shares in a company running pharmacies, taking into account the necessity to obtain UOKiK’s consent for the concentration. The transaction took into account issues arising from demo-geographical restrictions and the so-called “Pharmacy for Pharmacists” regulations.

Regulatory consultancy

We advised pharmacies operating as part of one of the largest franchise chains in Poland in proceedings before regulators related to their operations (both stationary and online). The project concerned the areas of pharmacy advertising and product marketing, transfer of business licenses, post-inspection events, private label and regulatory compliance.

Commercialisation of R&D at a scientific institute

We supported one of the scientific institutes of the Polish Academy of Sciences in the commercialisation of R&D projects. As part of the work we were responsible for securing innovative intellectual property and for developing a legally optimal path of commercialisation using special purpose vehicles.

Project leaders

Maciej Ślusarek Managing Partner
Maciej Kubiak Managing Partner
Tomasz Pieczyk Managing Partner
Joanna Groth Senior associate

News

3 July 2022

SKP lawyers received numerous recommendations in international rankings

In the first half of this year, our team earned a number of recommendations in international legal rankings. In many of them obtaining individual distinctions.   In […]

2 July 2022

Law for PR professionals with SKP experts

On 6 July, together with Puls Biznesu, we would like to invite you to a conference entitled: “Law in the hands of a PR specialist”, during which […]

1 July 2022

A well-coordinated team in a new structure – Welcome to SKP!

On 1 July 2022 SKP Ślusarek Kubiak Pieczyk, a law firm specialising in advising the creative sector, media, new technologies, life science and innovation in science and […]

Articles over coffee

  • Rok 2020 i pandemia koronawirusa na dobre zapisały się w naszej pamięci. Liczne restrykcje miały szczególne znaczenie dla lokali gastronomicznych, teatrów, kin, siłowni, galerii handlowych oraz oczywiście dla centrów konferencyjnych i eventowych venues. Aby w jakiś sposób poradzić sobie ze skutkami lockdownu przedsiębiorcy zaczęli powoływać się na klauzulę nadzwyczajnej zmiany stosunków, która umożliwia zmianę lub […]

  • 04.02.23

  • Jak co roku, Dyrektor Polskiego Instytutu Sztuki Filmowej, ogłosił nowe Programy Operacyjne, po ich zatwierdzeniu przez Radę PISF. Jakie nowości wprowadzono do Programów w tym roku? Przedstawiamy krótkie podsumowanie najistotniejszych zmian, z myślą o wszystkich aplikujących o dotacje, a w szczególności o producentach filmowych, którzy wnioski o dofinansowanie swoich projektów filmowych w pierwszej tegorocznej sesji […]

  • Od dnia 1 stycznia 2023 r. weszły w życie zmiany przepisów, które mają na celu wdrożenie do prawa polskiego trzech unijnych dyrektyw zwanych potocznie: dyrektywą Omnibus, dyrektywą towarową oraz dyrektywą cyfrową. Celem wprowadzanych zmian jest lepsza ochrona konsumentów, w szczególności przed nieuczciwymi (fikcyjnymi) promocjami towarów i usług oraz fałszywymi opiniami o produktach, które nie pochodzą […]

Contact

Warsaw

Ks. Skorupki Street 5
00-546 Warsaw

Sopot

Armii Krajowej Street 116/11
81-824 Sopot
+48 22 230 2655biuro@skplaw.pl
More
Copyright 2022 Privacy Policy Terms and conditions